Grants
- GAČR (24-11793S)
Elucidating the relationship between Trop2 expression and metastasis in cancer (2024-2026).
Co-Investigator: Petr Beneš - GAČR (23-0630K)
Tropomyosin Tpm2.3 isoform in regulation of actin dynamics and osteosarcoma metastasis (2023-2025).
Investigator: Petr Beneš - Ministry of Education, Youth and Sports of the Czech Republic (LX22NPO5102)
National Institute for Cancer Research (2022-2025).
Group leader: Petr Beneš - AZV NV18-07-00073
c-Myb and its transcriptional program in physiological and pathological osteogenic processes (2018-2021).
Investigator: Petr Beneš - GAČR (19-14727S)
Specification of osteogenic potential of caspases in context of craniofacial development (2019-2021).
Investigator: Petr Beneš - GAČR (GJ17-08985Y)
c-Myb-regulated inflammatory circuit in basal-like mammary tumors (2017-2019).
Investigator: Lucia Knopfova - GAMU (MUNI/G/0974/2016)
Optimization of colorectal carcinoma targeted therapy by enhancing the penetration and cytotoxicity of cell signaling regulators (2017-2019).
Investigator: Jarmila Navrátilová - Masaryk University Development Fund (MUNI/FR/1449/2016)
Inovation of practical courses of molecular biology methods (2017).
Investigator: Petr Benes - SCOPES-SNF Project No IZ73Z0_152361
c-Myb and Ruk/CIN85 modulate the signaling in breast cancer cells thereby affecting metastasis (2014-2017)
Investigator: Dr. Lubor Borsig, PhD, Co-investigator: Lucia Knopfová - IGA MZ ČR (NT13441-4/2012)
Expression of Myb family proteins in colon adenocarcinoma - relation to metastasis (2012-2015).
Investigator: Jan Smarda - Ministry of Education, Youth and Sports of the CR / Operational Programme Education for Competitiveness (CZ.1.07/2.3.00/20.0183)
Centrum experimentální biomedicíny (2012-2015).
Investigator: Jan Šmarda - Ministry of Education, Youth and Sports of the Czech Republic / Operational Programme Education for Competitiveness (CZ.1.07/2.4.00/31.0155)
Partnerství a sítě pro spolupráci v experimentální biologii (2013-2014).
Investigator: Jan Šmarda - CZ.1.07/2.2.00/07.0429
Modular structure of the studies focused on experimental biology (2009-2012).
Principal Investigator: Jan Šmarda - IGA MZ ČR (NS10448)
Detailed analysis of temperature-sensitive mutants of tumor suppressor p53 in human cancer cells (2009-2011).
Principal Investigator: Jana Šmardová - GAČR (GA301/09/1115)
The role of c-Myb and Cox-2 proteins in colon carcinogenesis" (2008 - 2012).
Principal Investigator: Jan Šmarda - GAAV (IAA501630801)
Mechanism of procathepsin D effect on breast cancer cells“ (2008 - 2011).
Principal Investigator: Petr Beneš - GAČR (GD2041/08/H054)
Molecular mechanisms of the cell proliferation and differentiation" (2008 - 2011).
Principal Investigator: Jan Šmarda - GAČR (301/06/0036)
Role of certain transcription factors in the osteoclastic differentiation pathway" (2006 - 2008).
Principal Investigator: Jan Šmarda - MŠMT (MSM0021622415)
Molecular pathways of cellular and tissue regulations" (2005 - 2011).
Principal Investigator: Jiří Fajkus - FRVŠ (111/2006)
Cell line RAW264.7 as a model for osteoclastogenesis in education and scientific training of students of Molecular Biology and Genetics" (2008)
Investigator: Petr Vaňhara - FRVŠ (1594/2005)
Innovation of practical courses of molecular biology" (2005).
Principal Investigator: Petr Beneš - GAČR (301/03/D022)
The role of vimentin in monocytic differentiation pathway" (2003 - 2006).
Principal Investigator: Petr Beneš - GAČR (301/03/1055)
Study of Molecular Mechanisms of v-Myb suppression using proteomics-based approach" (2003-2005).
Principal Investigator: Jan Šmarda - GAČR (301/01/040)
The role of Fos and Jun proteins in myeloid diferentiation idnuced by retinoic acid" (2001-2003).
Principal Investigator: Jan Šmarda - IGA MZ ČR (NM/16-3)
The role of CBP in anti-leukemic processes" (1999-2001).
Principal Investigator: Jana Šmardová - MŠMT ČR (MSM143100008)
Genomes and their functions" (1999 - 2004).
Principal Investigator: Jiřina Relichová - FRVŠ (2001)
Innovation of laboratories for teaching molecular biology and genetics at Faculty of Science, Masaryk University" (2001).
Principal investigator: Jiří Doškař - FRVŠ (0560/2001)
Innovation of practical courses of molecular biology" (2001).
Principal Investigator: Jan Šmarda - Barrande, France / Czech Republic (99039-2)
Use of BM2 cell line to sudy osteoclastic differentiation pathway II" (2000).
Principal Investigators: Pierre Jurdic, Jan Šmarda - Barrande, France / Czech Republic (99039-1)
Use of BM2 cell line to sudy osteoclastic differentiation pathway I" (1999).
Principal Investigators: Pierre Jurdic, Jan Šmarda - IGA MZ (NC4547)
Detection and monitoring of chromosomal abnormalities in children suffering from acute myeloid leukemia" (1998-2000).
Principal Investigator: Jan Šmarda - GAČR (312/98/0679)
Myb, Fos, Jun and retinoid receptor proteins in anti-leukemic processes" (1998-2000).
Principal Investigator: Jan Šmarda - FRVŠ (281/1997)
Introduction of modern methods of molecular and cellular biology to practical courses" (1997).
Principal Investigator: Jan Šmarda - FRVŠ (1996)
Molecular and Cellular Diagnostics" (1996).
Principal Investigator: Jiřina Relichová - Fogarty International Research Collaboration Award, National Institute of Health,USA (R03 TW00749)
The effects of AP-1 transcription factor on v-myb-transformed monoblasts" (1997-1999).
Principal Investigator: Joseph Lipsick - GAČR (301/96/K047)
Death of tumor cell by apoptosis-mechanisms of regulation, methods of detection and therapeutic implications"(1996-1998).
Principal Investigator: Jan Kovařík - GAČR (312/95/1212)
The role of retinoic acid receptors in myeloid differentiation" (1995-1997).
Principal Investigator: Jan Šmarda - Fogarty International Research Collaboration Award, National Institute of Health,USA (R03 TW00291)
The role of RAR and RXR in myeloid differentiation" (1994-1996).
Principal Investigator: Joseph Lipsick
Organizational structure:
Masaryk University › Faculty of Science › Department of Experimental Biology › Section of Genetics and Molecular Biology › Laboratory of Cell Differentiation